TAG
PRNewswire
Yingli Pharma presents a pivotal Phase 2 study data evaluating linperlisib in relapsed or refractory peripheral T-cell lymphoma in an oral session at the...
Linperlisib achieved Overall Response Rate of 48% with 30% being Complete Response and manageable safety profile in the r/r PTCL phase 2 study ...
China Literature to Acquire Tencent Animation and Comics
HONG KONG, Dec. 11, 2023 /PRNewswire/ -- China Literature Limited ("China Literature" or "the Company", stock code: 0772), a leading online literature and intellectual...
Global Times: Renowned French director Luc Besson brings latest work 'Dogman' to China
BEIJING, Dec. 11, 2023 /PRNewswire/ -- When Luc Besson's latest film Dogman hits Chinese cinemas, it is expected to further boost the rebounding Chinese box...
INNOVATION TO INSPIRE, A WONDEROUS FUTURE | Tianma 2023 Global Innovation Conference, Seven Innovative Achievements Unveiled
XIAMEN, China, Dec. 11, 2023 /PRNewswire/ -- On November 27th, Tianma Innovation Conference (TIC) 2023 was held in Xiamen with the theme of INNOVATION TO...
Keppel partners AM Green to explore biogenic carbon-based sustainable fuels opportunities in Asia and the Middle East
SINGAPORE and DUBAI, UAE, Dec. 11, 2023 /PRNewswire/ -- Keppel Corporation Limited (Keppel), through its Infrastructure Division, and AM Green, which is wholly owned...
Liangzhu Forum Enhances Cultural Exchanges among Silk Road Countries
HANGZHOU, China, Dec. 11, 2023 /PRNewswire/ -- A report from Xinhuanet North America: With "Implementing the Global...
